TriMas Corporation TRS
39.15
(0.32)
(0.81%)
as of 25 Sep
- Market cap
- $1.4B
- P/E
- 1.6×
Follow TRS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
35.45 | 11.78 | 1.49 | 1.87 |
P/S ratio |
2.98 | 1.88 | 1.76 | 2.10 | |
P/FCF ratio |
35.39 | 20.33 | 27.88 | 0.00 | |
P/Operating CF |
43.05 | 33.84 | (69.41) | (41.94) | |
P/B ratio |
2.17 | 1.99 | 0.93 | 1.12 | |
Price to Tangible BV |
8.74 | 4.27 | 1.25 | 1.51 | |
EV/Sales |
3.69 | 2.46 | 0.57 | 1.00 | |
EV/EBITDA |
26.37 | 38.87 | 9.03 | 16.41 | |
EV/Operating CF |
18.87 | 15.70 | 4.86 | 38.29 | |
EV/FCF |
43.81 | 26.69 | 8.96 | (67.61) | |
Quick Ratio |
1.25 | 0.77 | 4.39 | 4.91 | |
Current Ratio |
2.68 | 2.52 | 4.85 | 5.44 | |
Net Debt/EBITDA |
11.92 | (16.20) | (42.17) | (40.19) | |
Debt/Assets |
28.39% | 31.59% | 17.27% | 17.67% | |
Debt/Equity |
0.56 | 0.66 | 0.27 | 0.28 | |
Asset Turnover |
0.38 | 0.53 | 0.41 | 0.42 | |
Operating CF/Net income |
3.92 | 0.51 | (0.02) | (2.88) | |
Capex/Depreciation |
(0.93) | (0.32) | (0.35) | (0.78) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.28% | 24.54% | 17.82% | 14.03% | |
Intangible Assets out of Total Assets |
0.38 | 0.25 | 0.16 | 0.16 | |
Share Based Compensation of Revenue |
1.23% | 2.08% | 1.82% | 1.34% | |
Graham Net Nets |
(0.14) | (0.23) | 0.55 | 0.46 | |
Graham Number |
20.91 | 34.72 | 144.93 | 147.54 | |
Earnings Yield |
2.82% | 8.49% | 67.06% | 53.43% | |
Free Cash Flow Yield |
2.83% | 4.92% | 3.59% | (0.71%) | |
Revenue per Share |
6.62 | 3.92 | 4.50 | 4.87 | |
Operating CF per Share |
0.90 | 1.05 | (0.52) | (1.07) | |
Capex per Share |
(0.34) | (0.12) | (0.14) | (0.22) | |
Free Cash Flow per Share |
0.56 | 0.93 | (0.66) | (1.29) | |
Cash per Share |
0.83 | 0.76 | 34.99 | 34.63 | |
Shareholders Equity per Share |
17.84 | 17.80 | 38.74 | 40.21 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
17.84 | 17.80 | 38.74 | 40.21 | |
Free Cash Flow |
22.82 | 36.82 | (24.60) | (46.43) | |
Working Capital |
303.08 | 279.00 | 1,262.42 | 1,262.98 | |
Capital Expenditures |
(13.67) | (4.70) | (5.22) | (7.91) | |
Net Current Asset Value |
(225.67) | (316.82) | 742.62 | 744.12 | |
EV/EBIT |
251.52 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.03 | 0.03 | 0.05 | |
Net Profit Margin |
3.45% | 52.54% | 475.89% | 7.66% | |
Price to Operating Income |
203.20 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
177.66 | 113.43 | 156.23 | 178.71 | |
Average Payables |
85.58 | 72.32 | 177.27 | 163.08 | |
Average Inventory |
220.55 | 109.58 | 168.08 | 166.72 | |
Average Assets |
1,400.86 | 1,404.63 | 1,845.44 | 1,845.53 | |
Average Common Equity |
703.89 | 686.45 | 1,068.19 | 1,078.94 |
Columns are period end dates